Market revenue in 2023 | USD 801.5 million |
Market revenue in 2030 | USD 1.0 million |
Growth rate | -61.5% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Hospitals |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals |
Key market players worldwide | Merck & Co Inc, Amgen Inc, Roche, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries, Arbor Pharmaceuticals, Amneal Pharmaceuticals, Karyopharm Therapeutics Inc, Sumitomo Dainippon Pharma Oncology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe glioblastoma multiforme treatment market based on hospitals covering the revenue growth of each sub-segment from 2018 to 2030.
Europe held 30.25% share of Glioblastoma Multiforme (GBM) treatment market in 2020. Its growth can be attributed to consistent initiatives being undertaken by organizations, such as the NHS, European Organization for Research and Treatment of Cancer, and European Association of Neuro-Oncology: EANO.
The standard GBM treatment in Europe is surgery, followed by radiation + chemotherapy (Temozolomide and other off-label drugs). The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) declined to approve the only targeted therapy Avastin (bevacizumab) due to low efficacy of the product, which was unable to outweigh its risk.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe glioblastoma multiforme treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account